April 14 (Reuters) - OpenAI on Tuesday unveiled GPT-5.4-Cyber, a variant of its latest flagship model fine-tuned specifically ...
By Maggie Fick LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk, which has fallen behind Eli Lilly in the immensely ...
The OpenAI partnership is a credible productivity catalyst across discovery, manufacturing, and commercial ops, directly ...
As artificial intelligence continues to rewrite the rules in countless industries, pharma companies are increasingly getting ...
Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results